Showing results (1271-1280 of 1,291) with videos related to

Sort By:
Pageof 130
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetenceJennifer A Simonovich, Ryan A Clark, Alexander J Kwiatkowski, et al.
Cell Death & Disease|February 9, 2024
The small molecule raptinal can simultaneously induce apoptosis and inhibit PANX1 activityJascinta P Santavanond, Yu-Hsin Chiu, Rochelle Tixeira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2015
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ ReceptorsAlison L Tutt, Sonya James, Stéphanie A Laversin, et al.
Nature|January 21, 2026
Fibre integrated circuits by a multilayered spiral architectureZhen Wang, Ke Chen, Xiang Shi, et al.
BMC Cancer|October 5, 2024
Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimenMuh-Hwa Yang, Tien-Hua Chen, Hung-Ming Wang, et al.
The Science of the Total Environment|August 26, 2022
Associations between short-term exposure of ambient particulate matter and hemodialysis patients death: A nationwide, longitudinal case-control study in ChinaXiaowei Lou, Ping Zhang, Nan Shi, et al.
Human Molecular Genetics|February 20, 2010
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levelsMaja Barbalic, Josée Dupuis, Abbas Dehghan, et al.
Journal of Alzheimer'S Disease : JAD|March 21, 2025
Association between home dwelling situations, neighborhood social interactions, and subjective cognitive decline plus among older adults: A cross-sectional studyJing Liu, Dan Liu, Xin-Yan Xie, et al.
Cell Reports. Medicine|November 8, 2025
Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapyPo-Hsien Chiu, Kuan-Chen Lai, Hung-Ling Wang, et al.
Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.
Pageof 130